Skip to main content

Peer Review reports

From: Impact of Treviamet® & Treviamet XR® on quality of life besides glycemic control in type 2 DM patients

Original Submission
9 Aug 2023 Submitted Original manuscript
21 Aug 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
22 Aug 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
Resubmission - Version 2
21 Aug 2023 Submitted Manuscript version 2
28 Aug 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
Resubmission - Version 3
28 Aug 2023 Submitted Manuscript version 3
5 Sep 2023 Reviewed Reviewer Report - Ines Bilić-Ćurčić
6 Sep 2023 Reviewed Reviewer Report
25 Sep 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
Resubmission - Version 4
25 Sep 2023 Submitted Manuscript version 4
27 Sep 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
Resubmission - Version 5
27 Sep 2023 Submitted Manuscript version 5
28 Sep 2023 Reviewed Reviewer Report - Ines Bilić-Ćurčić
30 Sep 2023 Reviewed Reviewer Report
9 Oct 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
Resubmission - Version 6
9 Oct 2023 Submitted Manuscript version 6
10 Oct 2023 Author responded Author comments - Muhammad Adnan Kanpurwala
Resubmission - Version 7
10 Oct 2023 Submitted Manuscript version 7
16 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
17 Oct 2023 Editorially accepted
8 Nov 2023 Article published 10.1186/s12902-023-01492-2

You can find further information about peer review here.

Back to article page